References
- Umland TC , Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 A resolution. Nature structural biology 1994; 1(8):p.538–45.
- Yoneda K, Ultrastructural localization of phospholipases in the Clara cell of the rat bronchiole. The American journal of pathology 1978; 93(3):p.745–52.
- Van Vyve T , Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects. The Journal of allergy and clinical immunology 1995; 95(1 Pt 1):p.60–8.
- Benson, M., , Gene profiling reveals decreased expression of uteroglobin and other anti-inflammatory genes in nasal fluid cells from patients with intermittent allergic rhinitis. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005; 35(4):p.473–8.
- Lakind JS , A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2007 12(5):p.445–67.
- Shijubo N , Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1997; 10(5):p.1108–14.
- Hermans C and A Bernard, Lung epithelium-specific proteins: characteristics and potential applications as markers. American journal of respiratory and critical care medicine 1999; 159(2):p.646–78.
- Bernard A , Clara cell protein in serum and bronchoalveolar lavage. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992; 5(10): p. 1231–8.
- Pilette C , Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 2001; 163(1):p.185–94.
- Braido F , Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respiratory medicine 2007; 101(10):p.2119–24.
- Ye Q , Serum CC-10 in inflammatory lung diseases. Respiration; international review of thoracic diseases 2004; 71(5):p.505–10.
- Sin DD , Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC pulmonary medicine 2007; 7:p.13.
- Lomas DA , Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008; 63(12):p.1058–63.
- Broeckaert F , Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Annals of the New York Academy of Sciences 2000; 923:p.68–77.
- Hermans C , Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2003; 8(6):p.461–71.
- Vestbo J , Changes in forced expiratory volume in 1 second over time in COPD. The New England journal of medicine 2011; 365(13):p.1184–92.
- Celli BR , Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine 2012; 185(10):p.1065–1072.
- Lomas DA , An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. Journal of clinical pharmacology 2012; 52(3):p.416–24.
- Ge XN , Roflumilast increases Clara cell secretory protein in cigarette smoke-exposed mice. COPD 2009; 6(3):p.185–91.